Keyword Analysis & Research: ikarian capital
Keyword Research: People who searched ikarian capital also searched
Search Results related to ikarian capital on Search Engine
-
Ikarian Capital :: Welcome
http://www.ikariancapital.com/
WebIkarian Capital 100 CRESCENT CT,. Suite 1620. Dallas, TX 75201. [email protected]
DA: 74 PA: 4 MOZ Rank: 36
-
Ikarian Capital :: About Us
http://www.ikariancapital.com/about
WebIkarian Capital is a biotech investment firm focusing on innovations in drug discovery and development. Our team is led by professionals with deep scientific and biotech-specific finance backgrounds. We scour and select companies pursuing cutting edge science and demonstrating sound business fundamentals, spanning the spectrum of early- to late ...
DA: 44 PA: 65 MOZ Rank: 52
-
IKARIAN CAPITAL, LLC Top 13F Holdings - WhaleWisdom.com
https://whalewisdom.com/filer/ikarian-capital-llc
WebDec 31, 2023 · Ikarian Capital is a hedge fund with 5 clients and discretionary assets under management (AUM) of $375,072,066 (Form ADV from 2024-01-11). Their last reported 13F filing for Q4 2023 included $1,067,984,222 in managed 13F securities and a top 10 holdings concentration of 35.09%.
DA: 81 PA: 42 MOZ Rank: 87
-
Ikarian Capital LLC | LinkedIn
https://www.linkedin.com/company/ikarian-capital-llc
WebAbout us. Ikarian Capital LLC is an investment management firm founded in 2015 with offices in Dallas, Texas. We are a healthcare specialist firm that runs an event-driven long/short investment...
DA: 48 PA: 49 MOZ Rank: 45
-
Ikarian Capital 13F annual report (2024) | wallmine
https://wallmine.com/fund/40d/ikarian-capital-llc
WebAs of 7th February 2024, Ikarian Capital’s top holding is 70,000 shares of Argenx Se currently worth over $26.5 billion and making up 7.3% of the portfolio value. In addition, the fund holds 680,370 shares of Crinetics Pharmaceuticals In worth $24.2 billion.
DA: 23 PA: 27 MOZ Rank: 56
-
10 Stocks to Buy According to Neil Shahrestani’s Ikarian Capital
https://finance.yahoo.com/news/10-stocks-buy-according-neil-130159550.html
WebAug 3, 2021 · Ikarian Capital has majority of its investments in finance and healthcare sector. The hedge fund’s 13F portfolio is valued at approximately $2.96 billion as of the end of the first quarter of...
DA: 10 PA: 99 MOZ Rank: 69
-
Part 2A of Form ADV: Ikarian Capital, LLC Brochure
https://files.adviserinfo.sec.gov/IAPD/Content/Common/crd_iapd_Brochure.aspx?BRCHR_VRSN_ID=841168
WebIkarian has prepared this Part 2A of Form ADV (this “Brochure”) dated March 31, 2023 in connection with the annual updating amendment of its Form ADV. This Brochure replaces Ikarian’s last Brochure dated March 31, 2022. Since the last annual update, the following material changes to the Brochure have occurred:
DA: 96 PA: 76 MOZ Rank: 42
-
Ikarian Capital :: Contact
https://www.ikariancapital.com/contact
WebContact. IKARIAN CAPITAL. 100 Crescent Court. Suite 1620, Dallas, TX 75201. [email protected]. FOR MORE INFORMATION: Send.
DA: 79 PA: 18 MOZ Rank: 25
-
Dr. Neil Shahrestani - Co-Founder of Ikarian Capital - ideamensch
https://ideamensch.com/neil-shahrestani/
WebSep 6, 2017 · Burn the ships. Success is the only option. Dr. Neil Shahrestani is the Chief Investment Officer and co-founder of Ikarian Capital – an equity Long/Short biotech and pharmaceuticals focused hedge fund based in Dallas. Prior to co-founding Ikarian Capital, Neil graduated with honors from Columbia University with a degree in Economics and ...
DA: 92 PA: 98 MOZ Rank: 26
-
Ikarian Capital Fund Manager Profile | Preqin
https://www.preqin.com/data/profile/fund-manager/ikarian-capital/167495
WebFounded in Q1 of 2015 by Neil Shahrestani and Chart Westcott, Ikarian Capital is a long/short equity hedge fund manager focused on the therapeutics and biotechnology sub-sectors. The firm is based in Dallas, Texas. Read more. Asset Class. No. of Funds Currently Managed. Funds Raised in Last 10 Years. Est. Dry Powder. Strategies. Private Equity. -
DA: 46 PA: 97 MOZ Rank: 43